| Prostate-specific membrane antigen–targeted therapies for prostate cancer: towards improving therapeutic outcomes
Corpetti, M., Müller, C., Beltran, H., de Bono, J., & Theurillat, J. P. (2024). Prostate-specific membrane antigen–targeted therapies for prostate cancer: towards improving therapeutic outcomes. European Urology, 85(3), 193-204. https://doi.org/10.1016/j.eururo.2023.11.018 |
| Terbium-149 production: a focus on yield and quality improvement towards preclinical application
Favaretto, C., Grundler, P. V., Talip, Z., Köster, U., Johnston, K., Busslinger, S. D., … van der Meulen, N. P. (2024). Terbium-149 production: a focus on yield and quality improvement towards preclinical application. Scientific Reports, 14(1), 3284 (12 pp.). https://doi.org/10.1038/s41598-024-53610-2 |
| First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([<sup>161</sup>Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum
Fricke, J., Westerbergh, F., McDougall, L., Favaretto, C., Christ, E., Nicolas, G. P., … Wild, D. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517-2519. https://doi.org/10.1007/s00259-024-06641-w |
| Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours
Gomes, C. V., Mendes, B. M., Paixão, L., Gnesin, S., Müller, C., van der Meulen, N. P., … Lima, T. V. M. (2024). Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours. EJNMMI Physics, 11(1), 61 (14 pp.). https://doi.org/10.1186/s40658-024-00669-5 |
| Matrix metalloproteinase-responsive delivery of PEGylated fibroblast growth factor 2
Gutmann, M., Reinhardt, D., Seidensticker, C., Raschig, M., Hahn, L., Moscaroli, A., … Lühmann, T. (2024). Matrix metalloproteinase-responsive delivery of PEGylated fibroblast growth factor 2. ACS Biomaterials Science & Engineering, 10(1), 156-165. https://doi.org/10.1021/acsbiomaterials.3c01511 |
| Preclinical evaluation of gastrin-releasing peptide receptor antagonists labeled with <sup>161</sup>Tb and <sup>177</sup>Lu: a comparative study
Holzleitner, N., Cwojdzinski, T., Beck, R., Urtz-Urban, N., Hillhouse, C. C., Grundler, P. V., … Günther, T. (2024). Preclinical evaluation of gastrin-releasing peptide receptor antagonists labeled with 161Tb and 177Lu: a comparative study. Journal of Nuclear Medicine, 65(3), 481-484. https://doi.org/10.2967/jnumed.123.266233 |
| Development of wide range photon detection system for muonic X-ray spectroscopy
Mizuno, R., Niikura, M., Saito, T. Y., Matsuzaki, T., Sakurai, H., Amato, A., … Wang, C. (2024). Development of wide range photon detection system for muonic X-ray spectroscopy. Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, 1060, 169029 (14 pp.). https://doi.org/10.1016/j.nima.2023.169029 |
| In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [<sup>177</sup>Lu]Lu-PP-F11N in humans: the lumed phase 0b study
Rottenburger, C., Hentschel, M., Fürstner, M., McDougall, L., Kottoros, D., Kaul, F., … Wild, D. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI Research, 14(1), 37 (13 pp.). https://doi.org/10.1186/s13550-024-01101-w |
| Tumor growth-arrest effect of tetrahydroquinazoline-derivative human topoisomerase II-alpha inhibitor in HPV-negative head and neck squamous cell carcinoma
Sarogni, P., Brindani, N., Zamborlin, A., Gonnelli, A., Menicagli, M., Mapanao, A. K., … Voliani, V. (2024). Tumor growth-arrest effect of tetrahydroquinazoline-derivative human topoisomerase II-alpha inhibitor in HPV-negative head and neck squamous cell carcinoma. Scientific Reports, 14(1), 9150 (10 pp.). https://doi.org/10.1038/s41598-024-59592-5 |
| Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Scott, P. J. H., Penuelas, I., Rey, A., Aime, S., Ambikalmajan, P. M. R., Antunes, I. F., … Kopka, K. (2024). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharmacy and Chemistry, 9, 67 (20 pp.). https://doi.org/10.1186/s41181-024-00296-6 |
| Theranostics - a sure cure for cancer after 100 years?
Song, Y., Zou, J., Castellanos, E. A., Matsuura, N., Ronald, J. A., Shuhendler, A., … Chen, X. (2024). Theranostics - a sure cure for cancer after 100 years? Theranostics, 14(6), 2464-2488. https://doi.org/10.7150/thno.96675 |
| High-resolution cross section measurements for neutron interactions on <sup>89</sup>Y with incident neutron energies up to 95 keV
Tagliente, G., Milazzo, P. M., Paradela, C., Kopecky, S., Vescovi, D., Alaerts, G., … Žugec, P. (2024). High-resolution cross section measurements for neutron interactions on 89Y with incident neutron energies up to 95 keV. European Physical Journal A: Hadrons and Nuclei, 60(1), 21 (18 pp.). https://doi.org/10.1140/epja/s10050-024-01243-4 |
| Relaxed fibronectin: a potential novel target for imaging endometriotic lesions
Trachsel, B., Imobersteg, S., Valpreda, G., Singer, G., Grabherr, R., Ormos, M., … Béhé, M. (2024). Relaxed fibronectin: a potential novel target for imaging endometriotic lesions. EJNMMI Research, 14(1), 17 (11 pp.). https://doi.org/10.1186/s13550-024-01070-0 |
| Design and preclinical evaluation of a novel prostate-specific membrane antigen radioligand modified with a transthyretin binder
Vaccarin, C., Mapanao, A. K., Deberle, L. M., Becker, A. E., Borgna, F., Marzaro, G., … Müller, C. (2024). Design and preclinical evaluation of a novel prostate-specific membrane antigen radioligand modified with a transthyretin binder. Cancers, 16(7), 1262 (13 pp.). https://doi.org/10.3390/cancers16071262 |
| Synthesis and biological evaluation of pyrazole-pyrimidones as a new class of correctors of the cystic fibrosis transmembrane conductance regulator (CFTR)
Vaccarin, C., Veit, G., Hegedus, T., Torres, O., Chilin, A., Lukacs, G. L., & Marzaro, G. (2024). Synthesis and biological evaluation of pyrazole-pyrimidones as a new class of correctors of the cystic fibrosis transmembrane conductance regulator (CFTR). Journal of Medicinal Chemistry, 67, 13891-13908. https://doi.org/10.1021/acs.jmedchem.4c00685 |
| Liquid chromatography ICP-MS to assess the stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-based tumor-targeting agents towards the development of <sup>177</sup>Lu- and <sup>68</sup>Ga-labeled radiopharmaceuticals
Wallimann, R. H., Hensinger, H., Müller, C., Schibli, R., Kneuer, R., & Schindler, P. (2024). Liquid chromatography ICP-MS to assess the stability of 175Lu- and natGa-based tumor-targeting agents towards the development of 177Lu- and 68Ga-labeled radiopharmaceuticals. Pharmaceutics, 16(3), 299 (13 pp.). https://doi.org/10.3390/pharmaceutics16030299 |
| Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands
de Roode, K. E., Joosten, L., & Behe, M. (2024). Towards the magic radioactive bullet: improving targeted radionuclide therapy by reducing the renal retention of radioligands. Pharmaceuticals, 17(2), 256 (31 pp.). https://doi.org/10.3390/ph17020256 |
| Results of the <sup>244</sup>Cm, <sup>246</sup>Cm and <sup>248</sup>Cm neutron-induced capture cross sections measurements at EAR1 and EAR2 of the n_TOF facility
Alcayne, V., Mendoza, E., Cano-Ott, D., Kimura, A., Aberle, O., Amaducci, S., … Žugec, P. (2023). Results of the 244Cm, 246Cm and 248Cm neutron-induced capture cross sections measurements at EAR1 and EAR2 of the n_TOF facility. In C. M. Mattoon, R. Vogt, J. Escher, & I. Thompson (Eds.), EPJ web conferences: Vol. 284. 15th international conference on nuclear data for science and technology (ND2022) (p. 01009 (6 pp.). https://doi.org/10.1051/epjconf/202328401009 |
| A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides
Beyer, D., Vaccarin, C., Deupi, X., Mapanao, A. K., Cohrs, S., Sozzi-Guo, F., … Müller, C. (2023). A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides. EJNMMI Research, 13(1), 32 (14 pp.). https://doi.org/10.1186/s13550-023-00979-2 |
| The non-destructive investigation of a late antique knob bow fibula (Bügelknopffibel) from Kaiseraugst/CH using Muon Induced X-ray Emission (MIXE)
Biswas, S., Megatli-Niebel, I., Raselli, L., Simke, R., Cocolios, T. E., Deokar, N., … Amato, A. (2023). The non-destructive investigation of a late antique knob bow fibula (Bügelknopffibel) from Kaiseraugst/CH using Muon Induced X-ray Emission (MIXE). Heritage Science, 11, 43 (17 pp.). https://doi.org/10.1186/s40494-023-00880-0 |
